A 5-year-old girl with Down syndrome presents with fatigue, pallor, and hepatosplenomegaly. Complete blood count shows WBC 45,000/μL with 80% blasts, hemoglobin 6.5 g/dL, and platelets 25,000/μL. Flow cytometry reveals blasts positive for CD19, CD10, and TdT. Cytogenetics show t(12;21) in addition to trisomy 21. Her parents ask about prognosis compared to children without Down syndrome. Synthesizing genetic and prognostic factors, what is the most accurate statement?
Q2
A 16-year-old boy with Duchenne muscular dystrophy has progressive respiratory failure. His forced vital capacity is 25% predicted, and he requires BiPAP 18 hours daily. He develops pneumonia requiring intubation. After 3 weeks, he cannot be weaned from the ventilator. The pulmonologist recommends tracheostomy for long-term ventilation. The patient has normal cognition and states he does not want tracheostomy or prolonged ventilation, preferring comfort measures. His parents insist on tracheostomy. Evaluate the appropriate course of action.
Q3
A newborn undergoes screening and is found to have elevated 17-hydroxyprogesterone (17-OHP) levels. Follow-up testing confirms severely elevated 17-OHP, elevated ACTH, low cortisol, and low aldosterone. Karyotype is 46,XX. Genital examination shows clitoromegaly and partial labial fusion. The parents ask about gender assignment and immediate management. Evaluate the comprehensive management approach.
Q4
A 10-year-old girl with Marfan syndrome presents with sudden onset chest pain and dyspnea. She has a history of aortic root dilation (4.2 cm) and has been on atenolol therapy. Vital signs show BP 90/60 mmHg, HR 120/min. CT angiography reveals Stanford Type A aortic dissection. She requires emergency surgery but her parents are Jehovah's Witnesses and refuse blood transfusion. The surgical team estimates 80% mortality without transfusion versus 15% with transfusion. Analyze the ethical and legal approach.
Q5
A 4-year-old boy presents with recurrent bacterial infections, eczema, and thrombocytopenia with small platelets. Laboratory evaluation shows IgE 2,000 IU/mL, IgM low, and IgA normal. Flow cytometry reveals absent CD43 on T-cells. Genetic testing confirms a mutation in the WAS gene. His 2-year-old brother is asymptomatic but genetic testing shows he is also affected. Analyzing the genotype-phenotype correlation, what explains the phenotypic difference?
Q6
A 2-day-old male infant develops lethargy, poor feeding, and tachypnea. Laboratory studies show severe metabolic acidosis (pH 7.15), hyperammonemia (450 μmol/L), and ketosis. Plasma amino acid analysis reveals markedly elevated leucine, isoleucine, and valine. Urine organic acids show elevated branched-chain ketoacids. Analyzing the biochemical defect, what is the most appropriate initial management?
Q7
A 14-year-old girl with known Turner syndrome presents for routine follow-up. She has been receiving growth hormone therapy since age 6 and recently started estrogen replacement. Her blood pressure is 155/90 mmHg in the right arm and 145/85 mmHg in the left arm. Lower extremity pulses are 1+ bilaterally. Echocardiogram shows a bicuspid aortic valve. What additional screening is most appropriate at this time?
Q8
A 6-month-old infant of Ashkenazi Jewish descent presents with progressive weakness, exaggerated startle response to noise, and developmental regression. Fundoscopic examination reveals a cherry-red spot on the macula. Hexosaminidase A enzyme assay shows absent activity. The parents are planning another pregnancy and request genetic counseling. What is the recurrence risk for their next child?
Q9
A newborn boy delivered at 38 weeks presents with hypotonia, weak cry, and poor feeding. Physical examination reveals generalized muscle weakness, enlarged tongue, and cardiomegaly. Echocardiogram shows severe hypertrophic cardiomyopathy with left ventricular outflow obstruction. Muscle biopsy reveals glycogen accumulation within lysosomes. What enzyme deficiency best explains these findings?
Q10
A 3-year-old boy presents with developmental delay, coarse facial features, corneal clouding, and hepatosplenomegaly. His mother reports that he was developing normally until 18 months of age. Physical examination reveals claw-hand deformity and joint stiffness. Urine glycosaminoglycan analysis shows elevated dermatan and heparan sulfate. What is the most appropriate treatment to implement at this time?
Genetic disorders US Medical PG Practice Questions and MCQs
Question 1: A 5-year-old girl with Down syndrome presents with fatigue, pallor, and hepatosplenomegaly. Complete blood count shows WBC 45,000/μL with 80% blasts, hemoglobin 6.5 g/dL, and platelets 25,000/μL. Flow cytometry reveals blasts positive for CD19, CD10, and TdT. Cytogenetics show t(12;21) in addition to trisomy 21. Her parents ask about prognosis compared to children without Down syndrome. Synthesizing genetic and prognostic factors, what is the most accurate statement?
A. Down syndrome is associated with worse prognosis in ALL due to increased treatment-related mortality
B. The t(12;21) translocation negates any effect of Down syndrome on prognosis
C. Down syndrome children with ALL have better outcomes than non-Down syndrome children with comparable cytogenetics (Correct Answer)
D. Prognosis is identical to non-Down syndrome children when stratified by cytogenetics
E. Down syndrome mandates reduced-intensity chemotherapy with consequently worse outcomes
Explanation: ***Down syndrome children with ALL have better outcomes than non-Down syndrome children with comparable cytogenetics***
- Children with **Down syndrome (Trisomy 21)** and **B-cell ALL** demonstrate increased sensitivity to **Methotrexate** due to altered folate metabolism, leading to higher intracellular levels of active metabolites.
- When treated with contemporary protocols, this population exhibits improved **event-free survival** and overall survival compared to their non-syndromic peers.
*Down syndrome is associated with worse prognosis in ALL due to increased treatment-related mortality*
- While patients with Down syndrome experience higher **treatment-related toxicity** (specifically infections and mucositis), this does not lead to a poorer overall prognosis compared to the general population.
- The enhanced **chemosensitivity** of the blasts typically outweighs the risks of increased clinical toxicity.
*The t(12;21) translocation negates any effect of Down syndrome on prognosis*
- The **t(12;21) ETV6-RUNX1** translocation is a favorable prognostic marker, but its presence works synergistically with the biological advantages conferred by **Trisomy 21**.
- Down syndrome remains an independent factor in predicting **pharmacodynamic response** to therapy and does not become irrelevant due to cytogenetics.
*Prognosis is identical to non-Down syndrome children when stratified by cytogenetics*
- This statement is incorrect because children with Down syndrome have unique **pharmacogenetic profiles** that distinguish their response from the general population.
- Their blasts are significantly more sensitive to specific chemotherapeutic agents, resulting in better **minimal residual disease (MRD)** clearance.
*Down syndrome mandates reduced-intensity chemotherapy with consequently worse outcomes*
- Standard protocols are generally maintained, although **leucovorin rescue** may be adjusted to manage **methotrexate toxicity** without sacrificing efficacy.
- Reducing chemotherapy intensity is not a standard requirement and would potentially lead to higher **relapse rates**, which is not the observed clinical trend.
Question 2: A 16-year-old boy with Duchenne muscular dystrophy has progressive respiratory failure. His forced vital capacity is 25% predicted, and he requires BiPAP 18 hours daily. He develops pneumonia requiring intubation. After 3 weeks, he cannot be weaned from the ventilator. The pulmonologist recommends tracheostomy for long-term ventilation. The patient has normal cognition and states he does not want tracheostomy or prolonged ventilation, preferring comfort measures. His parents insist on tracheostomy. Evaluate the appropriate course of action.
A. Respect parental authority and proceed with tracheostomy
B. Follow the patient's wishes and transition to comfort care (Correct Answer)
C. Ethics consultation to mediate between patient and parents
D. Psychiatric evaluation to determine decision-making capacity
E. Continue current management until legal guardian is appointed
Explanation: ***Follow the patient's wishes and transition to comfort care***
- Adolescents with chronic, life-limiting illnesses like **Duchenne muscular dystrophy** often develop a high level of **medical maturity** and have the right to provide **assent or dissent** for life-prolonging treatments.
- Since the patient has **normal cognition** and understands his prognosis, his clear refusal of a tracheostomy should be respected over parental demands to avoid unnecessary suffering.
*Respect parental authority and proceed with tracheostomy*
- While parents are typically the **legal decision-makers**, their authority should not override a mature adolescent's refusal of **invasive, life-sustaining therapy** in terminal conditions.
- Proceeding against the patient's explicit will would violate his **bodily autonomy** and likely result in significant moral distress.
*Ethics consultation to mediate between patient and parents*
- An **ethics consultation** can be helpful for facilitation, but the ultimate clinical and ethical priority is the **autonomy of the mature minor** in this context.
- Mediation is a secondary step compared to the primary obligation to honor the patient's **informed refusal** of a permanent surgical intervention.
*Psychiatric evaluation to determine decision-making capacity*
- A psychiatric evaluation is unnecessary because the scenario states the patient has **normal cognition** and clear reasoning for his preference.
- **Decision-making capacity** is a clinical determination usually made by the treating physician; there is no evidence of depression or psychosis impairing his judgment.
*Continue current management until legal guardian is appointed*
- His parents are already his **legal guardians**, so waiting for a new appointment is legally unnecessary and prolongs his **ventilator dependence** against his will.
- Delaying the transition to **comfort measures** ignores the patient's immediate right to refuse invasive treatment as he nears the end of life.
Question 3: A newborn undergoes screening and is found to have elevated 17-hydroxyprogesterone (17-OHP) levels. Follow-up testing confirms severely elevated 17-OHP, elevated ACTH, low cortisol, and low aldosterone. Karyotype is 46,XX. Genital examination shows clitoromegaly and partial labial fusion. The parents ask about gender assignment and immediate management. Evaluate the comprehensive management approach.
A. Immediate gender reassignment to male with testosterone therapy
B. Female gender assignment with glucocorticoid and mineralocorticoid replacement, followed by surgical correction discussion (Correct Answer)
C. Delay all gender decisions until the child can participate in decision-making
D. Male gender assignment since external genitalia are virilized
E. Female assignment with immediate surgical correction before hospital discharge
Explanation: ***Female gender assignment with glucocorticoid and mineralocorticoid replacement, followed by surgical correction discussion***
- The patient has **21-hydroxylase deficiency** (classic salt-wasting CAH), necessitating immediate replacement of **hydrocortisone** and **fludrocortisone** to prevent life-threatening adrenal crisis.
- Since the karyotype is **46,XX**, these patients have normal female internal reproductive organs (ovaries and uterus) and are assigned **female gender** with future fertility potential.
*Immediate gender reassignment to male with testosterone therapy*
- This is inappropriate because the patient is a genetic female (**46,XX**) and testosterone would cause further **virilization** of a female infant.
- Exogenous testosterone is not indicated as CAH already involves an **excess of endogenous androgens** due to the enzyme block.
*Delay all gender decisions until the child can participate in decision-making*
- While some surgical aspects can be delayed, a **gender of assignment** is necessary for social and legal registration and psychological stability of the family.
- In 46,XX CAH, there is a strong consensus for female assignment due to the presence of **functional ovaries** and a uterus.
*Male gender assignment since external genitalia are virilized*
- External virilization (clitoromegaly) is a result of **excess androgens** in utero and does not reflect the genetic sex or internal anatomy.
- Assigning male gender to a 46,XX individual with a **uterus and ovaries** would lead to complex management issues at puberty, including menstruation and lack of testes.
*Female assignment with immediate surgical correction before hospital discharge*
- Medical stabilization of **electrolytes** and blood pressure is the absolute priority over elective cosmetic or reconstructive genital surgery.
- Current guidelines emphasize that **surgical correction** should involve a multidisciplinary team and careful discussion with parents regarding timing and the child's future autonomy.
Question 4: A 10-year-old girl with Marfan syndrome presents with sudden onset chest pain and dyspnea. She has a history of aortic root dilation (4.2 cm) and has been on atenolol therapy. Vital signs show BP 90/60 mmHg, HR 120/min. CT angiography reveals Stanford Type A aortic dissection. She requires emergency surgery but her parents are Jehovah's Witnesses and refuse blood transfusion. The surgical team estimates 80% mortality without transfusion versus 15% with transfusion. Analyze the ethical and legal approach.
A. Proceed with surgery using blood products under emergency doctrine
B. Obtain court order for transfusion as a minor (Correct Answer)
C. Respect parental autonomy and perform surgery without blood products
D. Transfer to a center experienced in bloodless cardiac surgery
E. Provide palliative care only per parental wishes
Explanation: ***Obtain court order for transfusion as a minor***
- In the case of a minor, the principle of **best interests of the child** overrides parental religious objections if the treatment is **life-saving** and no other alternative exists.
- Physicians should seek a **court-ordered mandate** or contact hospital legal services immediately to allow for transfusion while the child is still under legal care of the parents.
*Proceed with surgery using blood products under emergency doctrine*
- The **emergency doctrine** typically applies when legal guardians are **unavailable** to give consent for urgent, life-saving measures.
- Since the parents are present and actively refusing, proceeding without a **court order** or legal intervention could lead to legal complications, unless the child is actively dying and time does not permit a court contact.
*Respect parental autonomy and perform surgery without blood products*
- **Parental autonomy** is not absolute; parents do not have the right to refuse **life-saving medical treatment** for their children based on religious beliefs.
- Performing a high-risk surgery like a **Type A dissection** repair without blood products significantly increases mortality and violates the duty of **beneficence** toward the minor.
*Transfer to a center experienced in bloodless cardiac surgery*
- Stanford **Type A aortic dissection** is a surgical emergency with a high hourly mortality rate, making a **transfer clinically unsafe**.
- The delay required for transfer would likely result in **aortic rupture** or organ ischemia, further compromising the child's survival.
*Provide palliative care only per parental wishes*
- **Palliative care** is inappropriate in this scenario because the condition is treatable and the patient has a high chance of survival with standard **surgical intervention**.
- Withholding treatment for a reversible, life-threatening condition in a minor based solely on parental religious views constitutes **medical neglect**.
Question 5: A 4-year-old boy presents with recurrent bacterial infections, eczema, and thrombocytopenia with small platelets. Laboratory evaluation shows IgE 2,000 IU/mL, IgM low, and IgA normal. Flow cytometry reveals absent CD43 on T-cells. Genetic testing confirms a mutation in the WAS gene. His 2-year-old brother is asymptomatic but genetic testing shows he is also affected. Analyzing the genotype-phenotype correlation, what explains the phenotypic difference?
A. The symptomatic brother has a nonsense mutation while the asymptomatic brother has a missense mutation
B. X-chromosome inactivation patterns differ between the brothers
C. The asymptomatic brother has somatic reversion in hematopoietic cells (Correct Answer)
D. Modifier genes are providing protection in the asymptomatic brother
E. Environmental exposures have triggered disease in the symptomatic brother
Explanation: ***The asymptomatic brother has somatic reversion in hematopoietic cells***
- **Somatic reversion** is a phenomenon where a **germline mutation** spontaneously corrects itself in a subset of cells, often restoring **WASP expression** and functionality in specific hematopoietic lineages.
- This process creates a **mosaicism** that can significantly ameliorate or completely mask the clinical symptoms of **Wiskott-Aldrich Syndrome**, explaining why a genetically affected sibling remains asymptomatic.
*The symptomatic brother has a nonsense mutation while the asymptomatic brother has a missense mutation*
- The prompt states both brothers have "a mutation" in the same gene, implying they share the same **inherited genotype** within the family pedigree.
- In **X-linked recessive** families, siblings typically inherit the exact same pathogenic variant from the carrier mother unless a de novo event occurred, which is less likely than **reversion**.
*X-chromosome inactivation patterns differ between the brothers*
- **X-chromosome inactivation** (Lyonization) is a process that occurs in **females** to balance gene dosage between XX and XY individuals.
- As both brothers are **males** (XY), they only possess one X chromosome; therefore, inactivation patterns are not applicable to their phenotypic differences.
*Modifier genes are providing protection in the asymptomatic brother*
- While **modifier genes** can influence the severity of many genetic diseases, they rarely result in a complete lack of symptoms in a condition as severe as classic **Wiskott-Aldrich Syndrome**.
- **Somatic reversion** is a much more specific and well-documented mechanism for extreme phenotypic discordance between siblings with **WAS gene** mutations.
*Environmental exposures have triggered disease in the symptomatic brother*
- **Wiskott-Aldrich Syndrome** is a primary immunodeficiency defined by intrinsic defects in **T-cell signaling** and **platelet structure** (microthrombocytopenia).
- While environment affects infection frequency, it does not explain the absence of **thrombocytopenia** or **eczema** in a genetically affected individual; these are driven by the underlying **WASP protein** deficiency.
Question 6: A 2-day-old male infant develops lethargy, poor feeding, and tachypnea. Laboratory studies show severe metabolic acidosis (pH 7.15), hyperammonemia (450 μmol/L), and ketosis. Plasma amino acid analysis reveals markedly elevated leucine, isoleucine, and valine. Urine organic acids show elevated branched-chain ketoacids. Analyzing the biochemical defect, what is the most appropriate initial management?
A. Immediate hemodialysis, protein restriction, and thiamine supplementation (Correct Answer)
B. High-protein diet with carnitine supplementation
C. Arginine supplementation and sodium benzoate
D. Exchange transfusion and biotin supplementation
E. Glucose infusion and antibiotic therapy
Explanation: ***Immediate hemodialysis, protein restriction, and thiamine supplementation***
- The infant's symptoms and lab findings (elevated **leucine, isoleucine, and valine**) confirm **Maple Syrup Urine Disease (MSUD)**, necessitating urgent removal of toxic branched-chain amino acids and their ketoacids.
- **Thiamine (Vitamin B1)** is a cofactor for the **branched-chain alpha-ketoacid dehydrogenase** complex, and supplementation is used because some variants of the disease are thiamine-responsive.
*High-protein diet with carnitine supplementation*
- A **high-protein diet** would be detrimental, as it increases the load of branched-chain amino acids that the infant cannot metabolize.
- Carnitine is typically used in **organic acidemias** (like propionic or methylmalonic acidemia) rather than the primary management of classic MSUD.
*Arginine supplementation and sodium benzoate*
- This is the treatment for **Urea Cycle Defects**, which present with isolated **hyperammonemia** and respiratory alkalosis rather than metabolic ketoacidosis.
- **Sodium benzoate** acts as a nitrogen scavenger, which does not address the primary accumulation of branched-chain amino acids in MSUD.
*Exchange transfusion and biotin supplementation*
- **Exchange transfusion** is less efficient than hemodialysis for removing small water-soluble molecules like leucine in acute metabolic crises.
- **Biotin** is the cofactor for carboxylase enzymes and is indicated for **multiple carboxylase deficiency**, not MSUD.
*Glucose infusion and antibiotic therapy*
- While **glucose infusion** suppresses catabolism, it is insufficient as monotherapy for severe leucine elevation and metabolic acidosis.
- **Antibiotics** address potential sepsis, which can mimic metabolic crises, but they do not treat the underlying **biochemical defect** identified by the amino acid profile.
Question 7: A 14-year-old girl with known Turner syndrome presents for routine follow-up. She has been receiving growth hormone therapy since age 6 and recently started estrogen replacement. Her blood pressure is 155/90 mmHg in the right arm and 145/85 mmHg in the left arm. Lower extremity pulses are 1+ bilaterally. Echocardiogram shows a bicuspid aortic valve. What additional screening is most appropriate at this time?
A. CT angiography of the aorta to evaluate for coarctation (Correct Answer)
B. 24-hour urine catecholamines for pheochromocytoma
C. Renal ultrasound for polycystic kidney disease
D. Plasma aldosterone-to-renin ratio
E. Sleep study for obstructive sleep apnea
Explanation: ***CT angiography of the aorta to evaluate for coarctation***
- The patient presents with **hypertension**, weak **lower extremity pulses**, and a **bicuspid aortic valve**, which are classic clinical markers for **coarctation of the aorta** in Turner syndrome.
- Advanced imaging like **CT or MR angiography** is essential to visualize the site of narrowing and plan for surgical or endovascular repair.
*24-hour urine catecholamines for pheochromocytoma*
- While **pheochromocytoma** causes secondary hypertension, it is not specifically associated with Turner syndrome or **decreased femoral pulses**.
- It typically presents with episodic symptoms such as **paroxysmal headaches**, palpitations, and diaphoresis, which are absent here.
*Renal ultrasound for polycystic kidney disease*
- Patients with Turner syndrome are at higher risk for **renal anomalies** (like **horseshoe kidney**), but polycystic kidney disease is an unrelated genetic condition.
- Although renal issues can cause hypertension, they do not explain the **brachial-femoral pulse delay** or the presence of a bicuspid aortic valve.
*Plasma aldosterone-to-renin ratio*
- This test is used to screen for **primary aldosteronism**, which presents with hypertension and often **hypokalemia**, but not pulse discrepancies.
- There is no clinical reason to prioritize endocrine causes of hypertension over the obvious **structural cardiovascular findings** in this patient.
*Sleep study for obstructive sleep apnea*
- **Obstructive sleep apnea** (OSA) can lead to systemic hypertension, but it is more commonly associated with obesity or **craniofacial abnormalities**.
- A sleep study would not address the **bicuspid aortic valve** and 1+ bilateral lower extremity pulses which point toward a vascular obstruction.
Question 8: A 6-month-old infant of Ashkenazi Jewish descent presents with progressive weakness, exaggerated startle response to noise, and developmental regression. Fundoscopic examination reveals a cherry-red spot on the macula. Hexosaminidase A enzyme assay shows absent activity. The parents are planning another pregnancy and request genetic counseling. What is the recurrence risk for their next child?
A. 25% for each pregnancy (Correct Answer)
B. 50% for each pregnancy
C. 100% if the next child is male
D. Less than 1% with preimplantation genetic diagnosis
E. 0% if prenatal screening is negative
Explanation: ***25% for each pregnancy***
- The clinical presentation of **Tay-Sachs disease** (cherry-red spot, weakness, absent **Hexosaminidase A**) follows an **autosomal recessive** inheritance pattern.
- Since both parents have an affected child, they are **obligate carriers**, resulting in a **1 in 4 (25%)** risk of recurrence for each subsequent pregnancy regardless of biological sex.
*50% for each pregnancy*
- A 50% risk is characteristic of **autosomal dominant** conditions where one parent is affected or **carrier children** in autosomal recessive patterns.
- It does not represent the probability of the disease phenotype in an **autosomal recessive** disorder like Tay-Sachs.
*100% if the next child is male*
- This pattern would suggest a **Y-linked** or specific **X-linked** lethal condition, which is incorrect for Tay-Sachs disease.
- Tay-Sachs is located on **chromosome 15**, making its inheritance independent of the child's sex.
*Less than 1% with preimplantation genetic diagnosis*
- While **PGD** can significantly reduce the risk of implanting an affected embryo, it does not change the biological **recurrence risk** of the parents' gametes.
- The question asks for the **inherent recurrence risk** based on the parents' genetic status, which remains 25% for each natural conception.
*0% if prenatal screening is negative*
- A negative **prenatal screening** result (like amniocentesis or CVS) indicates that *specific* fetus is unaffected, but it does not alter the **25% risk** for future pregnancies.
- Furthermore, screening carries a minute risk of **false negatives** and does not change the carrier status of the parents.
Question 9: A newborn boy delivered at 38 weeks presents with hypotonia, weak cry, and poor feeding. Physical examination reveals generalized muscle weakness, enlarged tongue, and cardiomegaly. Echocardiogram shows severe hypertrophic cardiomyopathy with left ventricular outflow obstruction. Muscle biopsy reveals glycogen accumulation within lysosomes. What enzyme deficiency best explains these findings?
A. Acid maltase (acid α-glucosidase) (Correct Answer)
B. Glucose-6-phosphatase
C. Muscle phosphorylase
D. Debranching enzyme
E. Branching enzyme
Explanation: ***Acid maltase (acid α-glucosidase)***
- This enzyme deficiency causes **Pompe disease (GSD II)**, which is uniquely characterized by the accumulation of glycogen within **lysosomes**.
- Clinical hallmarks include infantile-onset **hypotonia**, **macroglossia**, and massive **hypertrophic cardiomyopathy**, leading to early heart failure.
*Glucose-6-phosphatase*
- Deficiency results in **von Gierke disease (GSD I)**, which primarily presents with severe **fasting hypoglycemia**, lactic acidosis, and hepatomegaly.
- It does not cause **cardiomegaly** or lysosomal glycogen accumulation as the defect is in the metabolic pathway of gluconeogenesis/glycogenolysis.
*Muscle phosphorylase*
- Deficiency leads to **McArdle disease (GSD V)**, which presents in adolescence or adulthood with **exercise-induced muscle cramps** and myoglobinuria.
- It does not affect the **heart** and does not present in the neonatal period with systemic hypotonia.
*Debranching enzyme*
- Deficiency causes **Cori disease (GSD III)**, manifesting with hepatomegaly, growth retardation, and mild **hypoglycemia**.
- While it can cause some cardiomyopathy, it is distinguished by **abnormal glycogen structure** (limit dextrins) rather than lysosomal storage.
*Branching enzyme*
- Deficiency results in **Andersen disease (GSD IV)**, which typically presents with **infantile liver cirrhosis** and failure to thrive.
- Accumulation consists of **polyglucosan bodies** (long, unbranched glucose chains) rather than normal glycogen within lysosomes.
Question 10: A 3-year-old boy presents with developmental delay, coarse facial features, corneal clouding, and hepatosplenomegaly. His mother reports that he was developing normally until 18 months of age. Physical examination reveals claw-hand deformity and joint stiffness. Urine glycosaminoglycan analysis shows elevated dermatan and heparan sulfate. What is the most appropriate treatment to implement at this time?
A. Enzyme replacement therapy with laronidase (Correct Answer)
B. Dietary restriction of mucopolysaccharides
C. High-dose vitamin supplementation
D. Symptomatic management with physical therapy only
E. Chelation therapy with penicillamine
Explanation: ***Enzyme replacement therapy with laronidase***
- The patient presents with **Hurler syndrome (MPS I)**, characterized by **corneal clouding**, **claw-hand deformity**, and **α-L-iduronidase** deficiency; **laronidase** is the specific recombinant enzyme used for treatment.
- Early initiation of **enzyme replacement therapy (ERT)** helps reduce **hepatosplenomegaly**, improves joint mobility, and stabilizes pulmonary function, though it does not cross the **blood-brain barrier** effectively.
*Dietary restriction of mucopolysaccharides*
- **Mucopolysaccharides** (glycosaminoglycans) are produced endogenously within lysosomes, so **dietary restriction** has no impact on their accumulation.
- Unlike disorders like **Phenylketonuria (PKU)**, nutritional management does not address the underlying enzymatic pathophysiology of **lysosomal storage diseases**.
*High-dose vitamin supplementation*
- Vitamin therapy is used for specific metabolic conditions like **homocystinuria** (B6) or **MSUD** (thiamine), but it has no role in treating **Hurler syndrome**.
- High-dose vitamins cannot bypass the lack of **α-L-iduronidase** or facilitate the breakdown of **dermatan and heparan sulfate**.
*Symptomatic management with physical therapy only*
- While **physical therapy** helps manage **joint stiffness** and **claw-hand deformities**, it is not a disease-modifying treatment and does not address the systemic enzyme deficiency.
- Relying solely on symptomatic care allows for progressive **neurodegeneration** and organ damage that could be mitigated by **ERT** or **stem cell transplantation**.
*Chelation therapy with penicillamine*
- **Penicillamine** is indicated for heavy metal poisoning or **Wilson's disease** to remove excess copper, which is not the pathology here.
- **Hurler syndrome** involves the accumulation of complex sugars, not metals, making **chelation therapy** entirely ineffective.
